Company News in the Life Science Industry

»

Reset 

MediWound Initiates U.S. Phase 2 Adaptive Design Study of EscharEx® for Treatment of Venous Leg Ulcers

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  MediWound Ltd.

Blueberries Medical Harvests First Commercial Crop & Progresses Towards Expected Sales in Early 2020

Read more ››
By: GlobenewsWire - 03 Dec 2019

BridgeBio Pharma’s Origin Biosciences Initiates Rolling Submission of New Drug Application with the U.S. FDA for BBP-870 for the Treatment of MoCD Type A

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  BridgeBio Inc.

BioSig Technologies Announces New Collaboration on Development of Artificial Intelligence Solutions in Healthcare

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  BioSig Technologies, Inc.

IntelGenx to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  IntelGenx Corp.

Kane Biotech Announces Conditional Research Award of Up To $3.4 Million

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Kane Biotech Inc.

Outlook Therapeutics Receives FDA Agreement for Three Special Protocol Assessments for Additional Planned Clinical Trials of ONS-5010

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Outlook Therapeutics, Inc.

Imagin Medical to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference

Read more ››
By: GlobenewsWire - 03 Dec 2019

Lively Donating $100 to the Hearing Loss Association of America for Hearing Aids Sold on Giving Tuesday 2019

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Lively

Centrexion Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Lead Pipeline Candidate CNTX-4975

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Centrexion Therapeutics Corporation

Immunomedics Resubmits Biologics License Application to the FDA for Sacituzumab Govitecan

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Immunomedics, Inc.

Dermavant Announces First Patient Dosed in Phase 2a Clinical Trial of Topical Dual JAK/Syk Inhibitor Cerdulatinib for Vitiligo

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Dermavant Sciences GmbH

Atreca Announces FDA Clearance of Investigational New Drug Application for ATRC-101

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Atreca, Inc.

CytoDyn Reports Early Results from First Patient in its Phase 1b/2 CCR5+ Metastatic Triple-Negative Breast Cancer Trial

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  CytoDyn, Inc.

HTG Molecular Diagnostics to Host Key Opinion Leader Meeting on the Future of Precision Medicine

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  HTG Molecular Diagnostics, Inc.

OWP Pharmaceuticals Announces a Second IND Approval and Patent Application: The First-Ever Liquid Oral Suspension Formulation of Lamotrigine for the Treatment of Epilepsy and Bipolar Disorder

Read more ››
By: GlobenewsWire - 03 Dec 2019

Cidara Therapeutics to Present at Two Upcoming Medical Conferences

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Cidara Therapeutics, Inc.

DNARx Announces Article in Science Advances about HEDGES™, DNARx’s Proprietary Nonviral Gene Therapy Platform that Overcomes Critical Viral Vector Limitations

Read more ››
By: GlobenewsWire - 03 Dec 2019

Transactions in relation to share buyback program

Read more ››
By: GlobenewsWire - 03 Dec 2019

Scientus Pharma to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference

Read more ››
By: GlobenewsWire - 03 Dec 2019
Related companies:  Scientus Pharma Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »

Explore our database of over 50,000 companies